You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 4, 2025

Drug Price Trends for NDC 55111-0629


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 55111-0629

Drug NameNDCPrice/Unit ($)UnitDate
ESZOPICLONE 1 MG TABLET 55111-0629-30 0.13331 EACH 2025-03-19
ESZOPICLONE 1 MG TABLET 55111-0629-30 0.12412 EACH 2025-02-19
ESZOPICLONE 1 MG TABLET 55111-0629-30 0.11946 EACH 2025-01-22
ESZOPICLONE 1 MG TABLET 55111-0629-30 0.12118 EACH 2024-12-18
ESZOPICLONE 1 MG TABLET 55111-0629-30 0.10879 EACH 2024-11-20
ESZOPICLONE 1 MG TABLET 55111-0629-30 0.14794 EACH 2024-10-23
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 6 of 6 entries

Best Wholesale Price for NDC 55111-0629

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for Drug NDC: 55111-0629

Introduction to the Drug

The drug with the NDC code 55111-0629 is Eszopiclone, a non-benzodiazepine hypnotic agent used for the treatment of insomnia. It is manufactured by Dr. Reddy's Laboratories Limited[4].

Current Market Context

Pharmaceutical Price Inflation

The pharmaceutical market is experiencing a notable increase in drug prices. According to Vizient's summer 2024 Pharmacy Market Outlook, the overall drug price inflation rate for 2025 is projected to be 3.81%. This inflation is driven by various factors, including the expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies[2][3].

Price Trends and Projections

General Price Increases

From January 2022 to January 2023, the average price increase for single-source drugs was 7.4%, while multi-source drugs saw an average increase of 26.0%. These increases are part of a broader trend where drug prices have been rising consistently over the past few years[5].

Specific to Eszopiclone

While the specific price trends for Eszopiclone (NDC: 55111-0629) are not detailed in the available sources, it is reasonable to assume that it may follow the general trend of pharmaceutical price inflation. Given that Eszopiclone is a multi-source drug, it might experience price increases similar to other multi-source drugs, which tend to have higher percentage increases compared to single-source drugs.

Factors Influencing Price

Market Competition

The presence of multiple manufacturers for Eszopiclone can influence its pricing. Dr. Reddy's Laboratories Limited, along with other generic manufacturers, contributes to the competitive landscape, which can sometimes mitigate significant price hikes[4].

Regulatory Environment

Regulatory changes and FDA approvals can impact drug pricing. For instance, the FDA's approval of new indications for existing drugs or the introduction of new therapies can drive up costs and influence the pricing of related medications[2].

Economic and Healthcare Trends

The increasing demand for insomnia treatments and the broader healthcare landscape can also affect pricing. As healthcare systems prepare for the integration of new, high-cost therapies, there may be a ripple effect on the pricing of other medications, including Eszopiclone[2][3].

Impact on Healthcare Providers and Patients

Budgetary and Operational Challenges

Healthcare providers face significant challenges in managing pharmacy spend due to rising drug prices. The introduction of high-cost therapies and the increasing spend on medications like semaglutide (up 77% since the summer 2023 Outlook) highlight the need for providers to prepare for these financial and operational impacts[2].

Patient Access and Affordability

Rising drug prices can affect patient access to necessary medications. For patients relying on Eszopiclone for insomnia treatment, any significant price increase could impact their ability to afford the medication, underscoring the need for sustainable pricing models.

Key Takeaways

  • Price Inflation: The overall drug price inflation rate for 2025 is projected to be 3.81%, which could impact the pricing of Eszopiclone.
  • Market Trends: Multi-source drugs like Eszopiclone tend to experience higher percentage price increases compared to single-source drugs.
  • Regulatory and Economic Factors: Changes in regulatory approvals and healthcare trends can influence the pricing of medications.
  • Impact on Healthcare: Rising drug prices pose budgetary and operational challenges for healthcare providers and affect patient access to medications.

FAQs

Q: What is the NDC code for Eszopiclone manufactured by Dr. Reddy's Laboratories Limited? A: The NDC code for Eszopiclone manufactured by Dr. Reddy's Laboratories Limited is 55111-0629[4].

Q: What is the projected overall drug price inflation rate for 2025? A: The projected overall drug price inflation rate for 2025 is 3.81% according to Vizient's summer 2024 Pharmacy Market Outlook[2].

Q: How do multi-source drugs like Eszopiclone typically experience price changes? A: Multi-source drugs tend to have higher percentage price increases compared to single-source drugs[5].

Q: What are some factors that could influence the pricing of Eszopiclone? A: Factors include market competition, regulatory changes, and broader healthcare trends[2][4].

Q: How might rising drug prices affect healthcare providers and patients? A: Rising drug prices can pose budgetary and operational challenges for healthcare providers and affect patient access to necessary medications[2].

Sources

  1. DailyMed: METOPROLOL SUCCINATE tablet, extended release - DailyMed
  2. Vizient Inc.: Vizient projects drug price inflation at 3.81%
  3. Vizient Inc.: Pharmacy Market Outlook Summer 2024 - Vizient Inc.
  4. FindACode: Dr.Reddy's Laboratories Limited - List of Drugs - NDC Labeler
  5. ASPE: Changes in the List Prices of Prescription Drugs, 2017-2023 - ASPE

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.